Clinical Trial Update: Maternal Smoking Exposure and Newborn Outcomes: Study Using Urinary Cotinine

View source ↗

Summary

This clinical trial update describes a study evaluating the impact of maternal smoking exposure on newborn outcomes, using urinary cotinine as a biomarker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Newborn

Snippet

Sponsor: Haseki Training and Research Hospital | Conditions: Tobacco Smoke Pollution, Maternal Exposure During Pregnancy | Status: NOT_YET_RECRUITING